Skip to main content
Erschienen in:

Open Access 18.03.2021 | Original Article

Cytotoxic effect of sodium hypochlorite (Lavanox 0.08%) and chlorhexidine gluconate (Irrisept 0.05%) on human osteoblasts

verfasst von: Sabrina Böhle, Eric Röhner, Timo Zippelius, Benjamin Jacob, Georg Matziolis, Sebastian Rohe

Erschienen in: European Journal of Orthopaedic Surgery & Traumatology | Ausgabe 1/2022

Abstract

Purpose

Soft tissue, bone and joint infections are severe complications in orthopedic and traumatological surgery. Lavanox (0.08% NaOCl) and Irrisept (0.05% chlorhexidine gluconate, CHG) are industrially produced antiseptic solutions commonly used in infection treatment. Regarding this clinical indication, the microbicidal effect is often investigated, but toxicity to osteoblasts has rarely been examined. This is important to decide whether these solutions should be used in septic situations in which bone healing must take place. The hypothesis of the present study is that NaOCl and CHG are cytotoxic to osteoblasts even after a short exposure time.

Methods

Human osteoblasts were isolated from donors with osteoarthritis during total knee and hip arthroplasty. Cells were cultivated and treated with both antiseptic solutions for 2, 5 and 10 min in different dilutions. Toxicity was quantified by counting cells, lactate dehydrogenase (LDH) expression, spectrophotometric quantification via XTT assay and FDA/PI fluorescence microscopy.

Results

Analyzing viable cells after treatment with both antiseptics showed a significant decrease in viable cells through LDH expression test, XTT assay, fluorescence microscopy and light microscopy, depending on concentration. The time dependence showed a trend to more cell death at longer exposure times, without significance.

Conclusion

Toxic effects on osteoblasts were shown after treatment with 0.08% NaOCl and 0.05% CHG after an exposure time of 2 min which also was concentration dependent. There was no difference in cytotoxicity between both antiseptics. In conclusion, these antiseptic solutions may be used with caution in situations requiring bone healing.
Trial registration number
Local ethics committee registration number: 5176–07/16
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s00590-021-02907-3.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Soft tissue, bone and joint infections are severe complications in orthopedic and traumatological surgery. Antiseptic solutions are used to reduce bacterial contamination in wounds. Industrially produced solutions in specific concentrations, e.g., sodium hypochlorite (NaOCl, Lavanox®, Serag-Wiessner GmbH, Naila, Germany) or chlorhexidine gluconate (CHG, Irrisept®, Irrimax Corporation, Lawrenceville, USA) are common in treatment of septic situations.
NaOCl is an effective agent against a wide range of microbes. It covers bacteria, mycobacteria, spores, viruses, algae and even protozoa [1]. In living organisms, hypochlorite is a useful biomolecule synthesized from hydrogen peroxide and chlorine ions catalyzed by the enzyme myeloperoxidase (MPO). It is secreted by activated phagocytes in zones of inflammation. HOCl is a key biological microbicidal agent, used as a natural defense owing to its great potency as a nucleophilic non-radical oxidant [2, 3].
Chlorhexidine is also an effective agent against microbes. In high concentrations, it damages the cell membrane, impairs DNA synthesis, and has a microbicidal effect. In lower concentrations, it acts by denaturation of cellular proteins with a bacteriostatic effect [4, 5].
Infection treatment in orthopedic and traumatological surgery must be performed frequently in situations requiring subsequent bone healing, e.g., fractures, osteotomies, arthrodesis, pseudarthrosis and bone grafts. The role of these topical antimicrobial agents is to limit bacterial proliferation without disturbing normal tissue or wound healing [6]. The microbicidal effect of both antiseptic solutions has been investigated extensively [4, 7, 8]. A cytotoxic time-dependent effect on fibroblasts (e.g., dermal and lung fibroblasts) in higher concentrations has also been described for both solutions [915].
To prevent tissue damage in our setting, the exposure time is limited to a few minutes, followed by irrigation with saline solution [16, 17], although most investigations about the bactericidal effect were performed using longer exposure times [4, 612, 18]. Nonetheless, there is a lack of knowledge about the effect of industrially solutions like Lavanox® or Irrisept® on osteoblasts, even after a shorter exposure time of just a few minutes.
The present study was therefore designed to investigate the effect of NaOCl (Lavanox® 0.08%) and chlorhexidine gluconate (CHG, Irrisept® 0.05%) on osteoblasts after different short exposure times and at different dilutions regarding an in vivo dilution due to local bleeding.

Materials and methods

Tissue culture plasticware was obtained from BD (Germany). Culture medium, phosphate buffer saline (PBS), trypsin solution, fetal calf serum (FCS) and all other reagents were obtained from Invitrogen (Karlsruhe, Germany) and Sigma-Aldrich (Merck KGaA, Darmstadt, Germany).
Antiseptic solutions NaOCl (0.08% sodium hypochlorite, Lavanox®, Serag-Wiessner GmbH und Co. KG, Naila, Germany) and CHG (0.05% chlorhexidine gluconate, Irrisept®, Irrimax Corporation, Lawrenceville GA, USA) were purchased. Fresh dilutions were produced for each experiment. The products were used in their original concentration 1:1 and at 1:5 and 1:25 dilutions (CHG: 1:1 0.05%, 1:5 0.01%, 1:25 0.002%; NaOCl: 1:1 0.08%, 1:5 0.016%, 1:25 0.0032%).

Osteoblast isolation, culture and treatment

Human bone tissue was obtained from seven donors who were suffering from knee or hip osteoarthritis according to a method previously described [19, 20]. Donors were included only if they did not present any signs of infection or tumor disease in clinical and blood examinations. After bone resection for total knee or total hip arthroplasty, the bone remnant was collected in a container under aseptic conditions. Within 2–5 h, bone fragments were separated from cartilage tissue and then minced manually into fragments sized 1–4 mm3. The bone fragments were then washed with PBS. Subsequently, they were suspended in osteogenic medium consisting of Dulbecco’s modified Eagle’s medium (DMEM) Ham’s F12 along with 10% FCS, 0.2% vitamin solution, 0.5% ß-glycerophosphate, 1% penicillin/streptomycin, and 0.01% dexamethasone, and finally cultured at 37 °C, 95% air and 5% CO2 establishing seven cell lines [19, 20]. After reaching subconfluency in a petri dish, cells were detached with 200 µl trypsin and transferred to a 75 cm2 and later to a 225 cm2 cell culture bottle.
Experiments were performed after osteoblast colonies had reached subconfluency again. Subsequently, osteoblasts were transferred and cultured on 24-well plates at a minimum density of 2.5 × 104 cells per well with 500 µl of medium. Then, they were treated with either 0.08% NaOCl or 0.05% CHG and their dilutions (1:5, 1:25) as well as with PBS (for XTT, LDH and microscopy) and medium (for FDA/PI) (negative control) and 2% Triton X-100 (positive control) for 2, 5 and 10 min. Each investigation consists of a triplicate determination with at least six different cell lines. Dilutions were produced with aqua ad injectabilia (B. Braun Melsungen AG, Melsungen, Germany).

Cell counting by light microscopy

After the described treatment above, human osteoblasts were washed with PBS and 200 µl trypsin releasing adherent cells. After this, a drop of the solution was placed into a counting chamber and counted by an automated cell counter (Cellometer Auto T4 Cell Counter, Nexcelom Bioscience, Lawrence, MA, USA).

XTT ELISA detection of viable cells

The XTT assay was used for the spectrophotometric quantification of cell viability. This analysis is based on the cleavage of the tetrazolium salt XTT to form a formazan dye by metabolic active cells. This conversion only occurs in viable cells. An increase in XTT activity is directly proportional to an increasing number of living cells. After treatment described above, cells were washed with PBS and incubated with the XTT solution for 2 h. After this incubation period, a formazan solution was formed, which was spectrophotometrically quantified at 450–500 nm using an ELISA plate reader (FLUOstar OPTIMA, Microplate Reader, BMG LABTECH, Ortenberg, Germany).

Detection of apoptosis and viability using fluorescence microscopy (FDA/PI)

Using fluorescence microscopy, the vital cells were stained with fluorescein diacetate (FDA) and the dead cells with propidium iodide (PI). FDA is taken up by cells that convert the non-fluorescent FDA into the green fluorescent metabolite fluorescein. The measured signal served as an indicator for viable cells, as the conversion was esterase dependent. In contrast, the nuclei staining dye PI cannot pass through a viable cell membrane. It reached the nucleus by passing through disordered areas of dead cell membranes and intercalated with the DNA double helix of the cell. After treatment described above and washing with PBS, cells were stained for 15 min with fluorescein diacetate and propidium iodide at a concentration of 20 µl per ml of medium. Documentation was undertaken immediately using fluorescence microscopy by counting viable and dead cells (microscope CKX 41, Olympus, Hamburg, Germany).

Activity of lactate dehydrogenase (LDH)

LDH activity is a marker of advanced cell death. LDH exposure indicates the loss of membrane plasma integrity as a possible marker of increased cell necrosis [21, 22]. After treatment described above, LDH activity was measured immediately colorimetrically in the supernatant of the well plate at 490–492 nm in the ELISA plate reader (FLUOstar OPTIMA, Microplate Reader, BMG LABTECH, Ortenberg, Germany). Measuring the LDH activity after incubation with NaOCl was not reliable. In 2006, Kending et al. showed an inactivation of LDH using H2O2 and other oxidants in living cell lines. NaOCl is also a nucleophilic non-radical oxidant and could lead to LDH inactivation, while CHG does not act as an oxidant. Based on the fact that NaOCl falsifies the LDH measurement, such data were not available for NaOCl [23].

Statistical analysis

Values were given as mean ± standard error of mean (SEM). To identify significant outliers, we used the Grubb’s test. The nonparametric Mann–Whitney U test was used as indicated in the legends. A p value of < 0.05 was considered to be significant.

Results

Bone was collected from seven male subjects (two knees and five hips) during total joint arthroplasties. The average age was 62.1 years (range 51–77 years). Negative and positive control showed always a significant difference (p ≤ 0.001).

Cell count by light microscopy

Using light microscopy for cell count, there was almost no cell death of osteoblasts when cultured with PBS (negative control) and a large number of dead cells after treatment with 2% Triton X-100 as known mediator of necrosis in human osteoblasts (Fig. 1). Non-diluted solutions of CHG at 2, 5 and 10 min and NaOCl at 5 and 10 min resulted in similar cytotoxicity. The cytotoxicity of non-diluted NaOCl after 2 min was lower than after 5 and 10 min, showing time dependence without reaching statistical significance. Both non-diluted solutions showed significantly fewer viable cells than PBS after 5 (p ≤ 0.03) and 10 min (p ≤ 0.004). CHG even shows a significant reduction of viable cells after 2 min (p ≤ 0.03). Diluted solutions of CHG and NaOCl showed a trend toward slightly more viable cells, without reaching statistical significance. After 10 min, non-diluted solutions of NaOCl showed a higher cytotoxicity than CHG. After 2 and 5 min of treatment, no significant difference was detectable (Fig. 1).

XTT assay

The XTT assay differentiated between viable and dead cells. There was almost no cell death with PBS (negative control), displayed by high XTT activity, and only a minimum XTT activity—indicating cell death—with Triton X-100 (positive control) (Fig. 2). Both antiseptic solutions showed a decrease in XTT activity depending on the exposure time, without reaching statistical significance. Both non-diluted and 1:5 diluted solutions showed significantly fewer viable cells than PBS at each time (p ≤ 0.002; p ≤ 0.035). At a 1:25 dilution only, CHG shows significant less XTT activity than PBS (p ≤ 0.035). We also detected significantly higher XTT activity at a 1:5 dilution of NaOCl and a 1:25 dilution of CHG, compared with non-diluted solutions, showing the concentration dependence (CHG after 2 min 1:1 vs. 1:25 p ≤ 0.004; after 5 min 1:1 vs. 1:25 p ≤ 0.026; after 10 min 1:1 vs. 1:25 p ≤ 0.026; NaOCl after 2 min 1:1 vs. 1:5 p ≤ 0.004; after 5 min 1:1 vs. 1:5 p ≤ 0.004; after 10 min 1:1 vs. 1:5 p ≤ 0.004). Except for non-diluted CHG and NaOCl, there was a trend toward more XTT activity—indicating cell viability—in the diluted NaOCl group compared with CHG over time and dilution. Against that, non-diluted NaOCl was more cytotoxic than non-diluted CHG after 2 and 5 min (p ≤ 0.02) (Fig. 2).

Fluorescence microscopy via FDA/PI staining

Fluorescence microscopy was used to detect viable and dead cells (Figs. 3 and 4). There was almost no cell death with medium (negative control) and almost no viable cells with Triton X-100 (positive control). The non-diluted solutions of both antiseptics had low viable cell numbers like Triton X-100 after 2, 5 and 10 min. Furthermore, the 1:5 dilution of CHG showed a cytotoxic effect comparable to Triton X-100 after 5 and 10 min. In summary, both non-diluted solutions showed significant less viable cells than the medium control (p ≤ 0.003). Regarding CHG, a longer exposure time of 5 min led to fewer viable cells in comparable dilutions at 2 min (p ≤ 0.01), while the exposure time of NaOCl had no significant effect on cell viability. They showed a significantly higher number of viable cells depending on the dilution of the antiseptics (CHG after 2 min 1:1. vs. 1:5 p ≤ 0.001, after 5 min 1:1 vs. 1:25 p ≤ 0.029 and after 10 min 1:1 vs. 1:5 p ≤ 0.035; NaOCl after 2 min 1:1 vs. 1:5 p ≤ 0.002, after 5 min 1:1 vs. 1:5 p ≤ 0.008 and after 10 min 1:1 vs. 1:5 p ≤ 0.001). Comparing NaOCl and CHG, we showed slightly more viable cells in the diluted NaOCl than the CHG group after 5 and 10 min, without reaching significance (Fig. 3).

LDH activity

LDH activity, indicating the onset of cell necrosis, was analyzed in the supernatant of each cell culture. There was almost no LDH release after incubation with PBS (negative control), but the highest concentration of LDH after incubation with Triton X-100 (positive control) after 2, 5 and 10 min (Fig. 4). After CHG treatment, the LDH activity increased with time of exposure. Non-diluted CHG showed significantly more cell necrosis than the negative control with PBS at each time (p ≤ 0.002). Furthermore, the LDH activity was concentration dependent, with higher LDH activity levels in less diluted CHG solutions at each time (CHG after 2 min 1:1 vs. 1:5 p ≤ 0.002; after 5 min 1:1 vs. 1:5 p ≤ 0.004; after 10 min 1:1 vs. 1:25 p ≤ 0.001). We did not obtain reliable results when measuring the LDH activity after incubation with NaOCl. In 2006, Kending et al. showed an inactivation of LDH using H2O2 and other oxidants in living cell lines [23]. NaOCl is also a nucleophilic non-radical oxidant and may lead to LDH inactivation, while CHG did not act as an oxidant. Consequently, a comparison between the two antiseptic solutions using the LDH activity test was not possible (Fig. 5).

Discussion

The main result of the present study was that NaOCl and CHG in industrially produced concentrations were toxic to human osteoblasts even after a short exposure time of 2, 5 and 10 min. This effect was concentration and time dependent.
In septic orthopedic and traumatological surgery, antiseptic solutions are used after surgical debridement to further reduce the microbicidal contamination of the tissues. Both investigated solutions are commonly used for antiseptic wound rinsing, although there is a lack of evidence about cytotoxicity toward human osteoblasts after short exposure times. There are several situations in which bone healing should not be compromised (e.g., fractures, osteotomies, arthrodesis, pseudarthrosis, bone grafts), and the solutions investigated should only be used if strictly indicated.
In dentistry, NaOCl is often used for rinsing at high concentrations and has been investigated thoroughly. Kerbl et al. and Bi et al. reported compromised cancellous bone integrity in dog and calf femur in an endodontic setting at high NaOCl concentrations (5.25% and 10%) [8, 9]. These data are supported by Goffin et al. who reported skin damage with comparably highly concentrated NaOCl (4%) [15]. Lineweaver et al. reported total destruction of fibroblasts after 15-min exposure with less concentrated NaOCl (0.5%) [6]. These effects seem to be concentration dependent according to the data of Kozol et al., who investigated neutrophil, fibroblast and endothelial cell viability after treatment with 0.025–0.0025% NaOCl for an exposure time of 30 min and reported cytoplasmic vacuolation, swollen mitochondria and dilated endoplasmic reticulum in fibroblasts and endothelial cells, but no cell deaths [14]. Sawada et al. showed a decrease in viable cells after 10-min rinsing with 0.25% NaOCl [11]. Vouzara et al. reported a cytotoxic effect of NaOCl on MRC5 cells (human lung fibroblasts) [12] and Hidalgo et al. on dermal fibroblasts, depending on concentration and exposure time [10]. Hidalgo et al. also investigated cytotoxicity of 0.00005 to 0.1% NaOCl to dermal fibroblasts after an exposure time of 2 to 24 h. Beginning cytotoxicity was described at a concentration of 0.0075% NaOCl after 8 h, increasing with concentrations higher than 0.025%, and leading to almost total cytotoxicity at 0.05% NaOCl [10]. Hidalgo et al. also showed a partial bactericidal effect of NaOCl at concentrations varying from 0.25 to 0.025%. NaOCl concentrations below 0.005% were totally devoid of bactericidal effects; for gram-negative bacteria, the cutoff is even 0.025% [10]. But there is still a lack of knowledge about the effect on human osteoblasts of less concentrated NaOCl after a short exposure time for intraoperative rinsing. In our study, we used 0.08% NaOCl and exposure times from 2 to 10 min and confirmed the reported cytotoxicity to osteoblasts, even after an essential shorter exposure time.
Hidalgo et al. also investigated the concentration-dependent cytotoxicity of CHG (0.0005 to 0.025%) to dermal fibroblasts after an exposure time of 3 to 24 h. They showed almost total cell death after 3 h for concentrations ≥ 0.005% CHG [5]. Vouzura et al. reported an even greater cytotoxic effect of CHG than that of NaOCl [12]. Sawada et al. showed a cytotoxic effect of CHG on the mandibular bone of pigs in vitro [4]. Van Meurs et al. reported a high cytotoxicity of CHG at a concentration required for a sufficient bactericidal effect [7]. They showed a concentration-dependent cytotoxicity of CHG on human fibroblasts after 2-min exposure, a minimal concentration for bactericidal effects of 0.078%, and a measurable cytotoxic effect beginning at 0.002% CHG [7]. Also, Liu et al. reported a concentration-dependent cell necrosis with survival rates of human myoblasts, fibroblasts and osteoblasts lower than 6% at concentrations ≥ 0.02% CHG [13]. In our study, we used a 0.05% CHG solution and confirmed the reported cytotoxicity for human osteoblasts for an exposure time between 2 and 10 min.
Comparing CHG to NaOCl, Sawada et al. reported a higher cytotoxic effect of NaOCl than CHG after investigating antiseptic solution in dentistry bone samples. They showed higher cell viability after rinsing with 0.2% CHG than 0.25% NaOCl for different exposure times [4, 11]. On the other hand, Vouzara et al. reported a higher cytotoxic effect of CHG than NaOCl on MRC5 cell samples at different concentrations of the solutions after 6 and 24 h [12]. In our study, there was no significant consistent difference in cytotoxicity between both solutions.
In the present work, direct effects of 0.08% NaOCl and 0.05% chlorhexidine gluconate on human osteoblasts were examined. We were able to demonstrate cell damage on the basis of cell necrosis [21, 22] and a reduction of viable cells after treatment with both antiseptic solutions, depending on exposure time and dilution.
This study has several limitations. The use of human osteoblasts from bone of patients with knee osteoarthritis yields bone tissue that is not fully intact, compared with the tissue in healthy people without osteoarthritis. The results of our study do not represent the in vivo situation, as in vitro results show higher cell toxicity than in vivo investigations based on direct osteoblast treatment without contact to blood and protecting serum components. In order to this, we tried to simulate the in vivo dilution by an artificial 1:5 dilution. Additionally, antiseptic solutions in vitro do not have to pass different barriers like intercellular matrix.

Conclusion

In summary, extensive toxic effects of 0.08% NaOCl and 0.05% CHG in industrially produced solutions on human osteoblasts were present even after a short incubation time of 2 min and after a dilution of 1:5 regarding in vivo dilutions due to bleeding. Comparing both solutions, there was no significant difference in their cytotoxicity to human osteoblasts consistently. Based on our results, both antiseptic solutions may be used with caution in situations requiring bone healing (e.g., fractures, osteotomies, arthrodesis, pseudarthrosis, and bone grafts). Therefore, we recommend a short exposure time less than 5 min and a wound rinsing with sterile saline solution after using them. We favor the use of Lavanox® because of a wider  microbicidal range against different types of microbes even with adherent biomembranes [1, 6, 24], but with subsequent lavage within 2–3 min contrary to manufacturer’s recommendation.

Compliance with ethical standards

Conflicts of interest

The authors declare that they have no conflict of interest.

Ethical approval

Ethic approval was given by the ethics committee of the University Jena with the registration number: 5176–07/16.
The authors declare their consent to participation.
The authors declare their consent for publication.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

e.Med Orthopädie & Unfallchirurgie

Kombi-Abonnement

Mit e.Med Orthopädie & Unfallchirurgie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Anhänge

Supplementary Information

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Rutala WA, Weber DJ (1997) Uses of inorganic hypochlorite (bleach) in health-care facilities. Clin Microbiol Rev 10:597–610CrossRef Rutala WA, Weber DJ (1997) Uses of inorganic hypochlorite (bleach) in health-care facilities. Clin Microbiol Rev 10:597–610CrossRef
2.
Zurück zum Zitat Lapenna D, Cuccurullo F (1996) Hypochlorous acid and its pharmacological antagonism: an update picture. Gen Pharmacol 27:1145–1147CrossRef Lapenna D, Cuccurullo F (1996) Hypochlorous acid and its pharmacological antagonism: an update picture. Gen Pharmacol 27:1145–1147CrossRef
5.
Zurück zum Zitat Hidalgo E, Dominguez C (2001) Mechanisms underlying chlorhexidine-induced cytotoxicity. Toxicol In Vitro 15:271–276CrossRef Hidalgo E, Dominguez C (2001) Mechanisms underlying chlorhexidine-induced cytotoxicity. Toxicol In Vitro 15:271–276CrossRef
6.
Zurück zum Zitat Lineaweaver W, Howard R, Soucy D et al (1985) Topical antimicrobial toxicity. Arch Surg 120:267–270CrossRef Lineaweaver W, Howard R, Soucy D et al (1985) Topical antimicrobial toxicity. Arch Surg 120:267–270CrossRef
14.
Zurück zum Zitat Kozol RA, Gillies C, Elgebaly SA (1988) Effects of sodium hypochlorite (Dakin’s solution) on cells of the wound module. Arch Surg 123:420–423CrossRef Kozol RA, Gillies C, Elgebaly SA (1988) Effects of sodium hypochlorite (Dakin’s solution) on cells of the wound module. Arch Surg 123:420–423CrossRef
21.
Zurück zum Zitat Bühling KJ, Lepenies J, Witt K (2008) Intensivkurs allgemeine und spezielle Pathologie: [mit dem Plus im Web; Zugangscode im Buch], 4, aktualisierte. Klinik. Elsevier Urban & Fischer, München Bühling KJ, Lepenies J, Witt K (2008) Intensivkurs allgemeine und spezielle Pathologie: [mit dem Plus im Web; Zugangscode im Buch], 4, aktualisierte. Klinik. Elsevier Urban & Fischer, München
22.
Zurück zum Zitat Walker NI, Harmon BV, Gobé GC et al (1988) Patterns of cell death. Methods Achiev Exp Pathol 13:18–54PubMed Walker NI, Harmon BV, Gobé GC et al (1988) Patterns of cell death. Methods Achiev Exp Pathol 13:18–54PubMed
Metadaten
Titel
Cytotoxic effect of sodium hypochlorite (Lavanox 0.08%) and chlorhexidine gluconate (Irrisept 0.05%) on human osteoblasts
verfasst von
Sabrina Böhle
Eric Röhner
Timo Zippelius
Benjamin Jacob
Georg Matziolis
Sebastian Rohe
Publikationsdatum
18.03.2021
Verlag
Springer Paris
Erschienen in
European Journal of Orthopaedic Surgery & Traumatology / Ausgabe 1/2022
Print ISSN: 1633-8065
Elektronische ISSN: 1432-1068
DOI
https://doi.org/10.1007/s00590-021-02907-3

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie erweitert durch Fallbeispiele, Videos und Abbildungen. Zur Fortbildung und Wissenserweiterung, verfasst und geprüft von Expertinnen und Experten der Gesellschaft für Arthroskopie und Gelenkchirurgie (AGA).


Jetzt entdecken!

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Nackenschmerzen nach Bandscheibenvorfall: Muskeltraining hilft!

Bei hartnäckigen Schmerzen aufgrund einer zervikalen Radikulopathie schlägt ein Team der Universität Istanbul vor, lokale Steroidinjektionen mit einem speziellen Trainingsprogramm zur Stabilisierung der Nackenmuskulatur zu kombinieren.

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Was sich Menschen mit Frozen Shoulder wünschen

Die Capsulitis adhaesiva des Glenohumeralgelenks, auch als Frozen Shoulder bezeichnet, belastet die Betroffenen weit über die körperlichen Beschwerden hinaus, wie eine italienische Studie ergeben hat.

Restriktive Sauerstoffgabe ohne Vorteil bei schwerem Trauma

Ob schwer verletzte Personen besser restriktiv oder liberal mit Sauerstoff versorgt werden sollten, hat die Arbeitsgruppe der TRAUMOX2-Studie untersucht – mit klarem Ergebnis.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.